We are live on
!
Find out more
SEC
Seven Eight Capital Portfolio holdings
AUM
$1.11B
1-Year Est. Return
29.48%
This Fund
S&P 500
This Quarter
Est. Return
+14.58%
1 Year Est. Return
+29.48%
3 Year Est. Return
+13.61%
5 Year Est. Return
+117.69%
10 Year Est. Return
+239.1%
AUM
$865M
AUM Growth
+$9.54M
(+1.1%)
Cap. Flow
-$78.4M
Cap. Flow
% of AUM
-9.07%
Top 10 Holdings %
Top 10 Hldgs %
8.56%
Holding
892
New
315
Increased
150
Reduced
128
Closed
299
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
XP
XP
|
+$7.27M |
| 2 |
Constellation Brands
STZ
|
+$7.01M |
| 3 |
Eli Lilly
LLY
|
+$6.9M |
| 4 |
Automatic Data Processing
ADP
|
+$6.79M |
| 5 |
Nu Holdings
NU
|
+$6.73M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$11.9M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$11.9M |
| 3 |
Microsoft
MSFT
|
+$11.8M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$11.7M |
| 5 |
Las Vegas Sands
LVS
|
+$11.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.67% |
| 2 | Healthcare | 18.49% |
| 3 | Consumer Discretionary | 15.79% |
| 4 | Industrials | 10.31% |
| 5 | Financials | 10.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
526
MSC Industrial Direct
MSM
$7.02B
| $285K | 0.03% |
+2,816
| New | +$279K |
|
527
Ralph Lauren
RL
$22.8B
| $283K | 0.03% |
+1,966
| New | +$243K |
|
528
Carter's
CRI
$1.46B
| $274K | 0.03% |
3,663
+273
| +8% | +$19K |
|
529
Grocery Outlet
GO
$975M
| $274K | 0.03% |
+10,161
| New | +$285K |
|
530
Canadian Pacific Kansas City
CP
$79.1B
| $273K | 0.03% |
3,458
-11,899
| -77% | -$871K |
|
531
Lithia Motors
LAD
$8.12B
| $272K | 0.03% |
+827
| New | +$227K |
|
532
Watsco Inc
WSO
$13.5B
| $272K | 0.03% |
+635
| New | +$246K |
|
|
AEL
533
DELISTED
American Equity Investment Life Holding Company
AEL
| $269K | 0.03% |
4,819
-4,576
| -49% | -$249K |
|
534
CDW
CDW
$19.1B
| $267K | 0.03% |
1,173
-2,943
| -72% | -$624K |
|
535
FTI Consulting
FCN
$4.31B
| $266K | 0.03% |
+1,335
| New | +$276K |
|
536
Sibanye-Stillwater
SBSW
$6.76B
| $265K | 0.03% |
+48,860
| New | +$253K |
|
537
Xcel Energy
XEL
$48.2B
| $263K | 0.03% |
4,251
-41,667
| -91% | -$2.5M |
|
538
Sweetgreen
SG
$698M
| $261K | 0.03% |
+23,113
| New | +$243K |
|
539
Ollie's Bargain Outlet
OLLI
$4.52B
| $261K | 0.03% |
3,441
-226
| -6% | -$17K |
|
|
RCM
540
DELISTED
R1 RCM Inc. Common Stock
RCM
| $260K | 0.03% |
+24,600
| New | +$279K |
|
541
O'Reilly Automotive
ORLY
$73.5B
| $258K | 0.03% |
4,080
-72,450
| -95% | -$4.58M |
|
542
Reinsurance Group of America
RGA
$15.5B
| $258K | 0.03% |
+1,594
| New | +$248K |
|
543
Republic Services
RSG
$63.8B
| $258K | 0.03% |
+1,563
| New | +$242K |
|
544
Evercore
EVR
$12.5B
| $257K | 0.03% |
+1,501
| New | +$217K |
|
545
Huntington Bancshares
HBAN
$35.5B
| $256K | 0.03% |
+20,129
| New | +$220K |
|
546
PJT Partners
PJT
$4.38B
| $255K | 0.03% |
+2,506
| New | +$215K |
|
547
Papa John's
PZZA
$1.01B
| $255K | 0.03% |
+3,345
| New | +$228K |
|
548
Penske Automotive Group
PAG
$14.3B
| $255K | 0.03% |
1,586
-586
| -27% | -$89.8K |
|
549
MaxLinear
MXL
$6.54B
| $254K | 0.03% |
10,700
-59,704
| -85% | -$1.17M |
|
550
Harmony Biosciences
HRMY
$2.26B
| $250K | 0.03% |
+7,736
| New | +$216K |
|
Similar funds
PP
ECM
GCAC
CAM
D
GFS
FTIS
AIA
Seven Eight Capital's Q4 2023 Portfolio in Review
As of Q4 2023, Seven Eight Capital held 892 positions worth $865M, up 1.1% from $855M the previous quarter. Its ten largest holdings account for 8.6% of the portfolio.
Seven Eight Capital withdrew a net $78.4M in Q4 2023, closing 299 positions and reducing 128 holdings. Its most notable exit was Merck, an estimated $11.9M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Seven Eight Capital opened a new position in XP worth $8.3M.
- Seven Eight Capital's largest Q4 2023 buy was XP: 318,542 shares worth $8.3M.
- Seven Eight Capital added most to Constellation Brands in Q4 2023, an estimated $7.01M increase.
- Seven Eight Capital's biggest Q4 2023 reduction was Vertex Pharmaceuticals, cutting an estimated $11.9M.
- Seven Eight Capital fully exited Merck in Q4 2023, selling an estimated $11.9M.
- Seven Eight Capital's ten largest holdings make up 8.6% of its $865M portfolio in Q4 2023.
- Seven Eight Capital opened 315 new positions and closed 299 in Q4 2023.
- Seven Eight Capital's portfolio value rose 1.1% quarter-over-quarter to $865M.
Based on Seven Eight Capital's 13F filing for Q4 2023, filed 13 Feb 2024.